Loading...
Loading...
K12
LRN soared 13.66% to $24.30 in the pre-market trading. K12 reported a better-than-expected fourth-quarter profit.
Vical
VICL surged 9.28% to $4.12 in the pre-market session. Vical announced today a worldwide, nonexclusive license to Bristol-Myers Squibb Company
BMY.
Cliffs Natural Resources
CLF added 2.41% to $41.60 in the pre-market session. Cliffs Natural Resources' PEG ratio is 1.09.
Arena Pharmaceuticals
ARNA moved up 1.79% to $8.51 in the pre-market session. Arena Pharmaceuticals shares have surged 464.87% over the past 52 weeks, while the S&P 500 index has gained 20.85% in the same period.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsPre-Market OutlookMarketsMoversConsumer DiscretionaryEducation ServicesTop Pre-Market Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in